Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Reform Vs. Improvements: No Decision Yet On Fate Of EU Advanced Therapies Law

This article was originally published in The Pink Sheet Daily

Executive Summary

Regulatory framework for gene therapy and tissue-engineered products is seen as inflexible and unclear, but policymakers have yet to decide on whether to fix what's there or aim for a legislative change.


Related Content

EMA's Action Plan To Support ATMPs Expected In Jan 2017